Evans DG - Search Results

1

Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).

Howell A, Gandhi A, Howell S, Wilson M, Maxwell A, Astley S, Harvie M, Pegington M, Barr L, Baildam A, Harkness E, Hopwood P, Wisely J, Wilding A, Greenhalgh R, Affen J, Maurice A, Cole S, Wiseman J, Lalloo F, French DP, Evans DG. Howell A, et al. Among authors: evans dg. Cancers (Basel). 2020 Dec 9;12(12):3697. doi: 10.3390/cancers12123697. Cancers (Basel). 2020. PMID: 33317064 Free PMC article.

2

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG. Antoniou AC, et al. Among authors: evans dg. Breast Cancer Res. 2006;8(6):R72. doi: 10.1186/bcr1630. Breast Cancer Res. 2006. PMID: 17187672 Free PMC article.

3

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.

Moller P, Evans DG, Reis MM, Gregory H, Anderson E, Maehle L, Lalloo F, Howell A, Apold J, Clark N, Lucassen A, Steel CM. Moller P, et al. Among authors: evans dg. Int J Cancer. 2007 Sep 1;121(5):1017-20. doi: 10.1002/ijc.22789. Int J Cancer. 2007. PMID: 17471561 Free article.

4

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER. Evans DG, et al. BMC Cancer. 2008 May 30;8:155. doi: 10.1186/1471-2407-8-155. BMC Cancer. 2008. PMID: 18513387 Free PMC article.

5

Impaired tamoxifen metabolism reduces survival in familial breast cancer patients.

Newman WG, Hadfield KD, Latif A, Roberts SA, Shenton A, McHague C, Lalloo F, Howell S, Evans DG. Newman WG, et al. Among authors: evans dg. Clin Cancer Res. 2008 Sep 15;14(18):5913-8. doi: 10.1158/1078-0432.CCR-07-5235. Clin Cancer Res. 2008. PMID: 18794105

6

Breast cancer susceptibility variants alter risks in familial disease.

Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, Black GC, Howell A, Evans DG, Newman WG. Latif A, et al. Among authors: evans dg. J Med Genet. 2010 Feb;47(2):126-31. doi: 10.1136/jmg.2009.067256. Epub 2009 Jul 16. J Med Genet. 2010. PMID: 19617217

7

Update on genetic predisposition to breast cancer.

Ahmed M, Lalloo F, Evans DG. Ahmed M, et al. Among authors: evans dg. Expert Rev Anticancer Ther. 2009 Aug;9(8):1103-13. doi: 10.1586/era.09.38. Expert Rev Anticancer Ther. 2009. PMID: 19671030 Review.

8

BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries.

Evans DG, Ahmed M, Bayliss S, Howard E, Lalloo F, Wallace A. Evans DG, et al. J Med Genet. 2010 Aug;47(8):561-6. doi: 10.1136/jmg.2009.075770. Epub 2010 May 14. J Med Genet. 2010. PMID: 20472656

9

Uptake of breast cancer prevention and screening trials.

Evans DG, Harvie M, Bundred N, Howell A. Evans DG, et al. J Med Genet. 2010 Dec;47(12):853-5. doi: 10.1136/jmg.2010.082768. Epub 2010 Oct 23. J Med Genet. 2010. PMID: 20972247

10

Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.

FH01 collaborative teams. FH01 collaborative teams. Lancet Oncol. 2010 Dec;11(12):1127-34. doi: 10.1016/S1470-2045(10)70263-1. Epub 2010 Nov 17. Lancet Oncol. 2010. PMID: 21093374 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,326 results

Search Page